Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUMA1 antisense RNA 1 (NUMA1-AS1)
- Target
- NUMA1-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Antisense RNA, Other (noncoding RNA)
01
Overview
NUMA1 antisense RNA 1 (NUMA1-AS1) is a long noncoding RNA gene expressed antisense to the nuclear mitotic apparatus protein 1 (NUMA1) locus. Like other lncRNA antisense transcripts, it may function in gene regulation at the transcriptional or posttranscriptional level, potentially influencing NUMA1 gene expression through mechanisms such as transcriptional interference, chromatin remodeling, or RNA-mediated silencing, although no experimentally validated roles are confirmed for NUMA1-AS1 to date. NUMA1-AS1’s sequence, expression pattern, and physiological significance remain largely uncharacterized in the current scientific literature.
- Other names
- NUMA1-AS1NUMA1 antisense RNA 1
02
Mechanism of action
Not applicable; no drugs are known to act on this molecule.
03
Biological functions
Regulation of gene expression (by antisense transcription mechanisms, general to antisense RNAs)Epigenetic or transcriptional regulation (inferred from known antisense RNA functions, not experimentally validated for NUMA1-AS1 specifically)
04
Disease associations
None directly reported for NUMA1-AS1. There is evidence for antisense RNAs generally in cancer or developmental disease, but no published association specific to NUMA1-AS1
05
Safety considerations
None known. No therapeutic interventions or safety concerns are reported for NUMA1-AS1
06
Interacting drugs
None known. There are no documented pharmacological ligands, inhibitors, or drugs that target NUMA1-AS1
07
Biomarkers
None known. NUMA1-AS1 is not reported as a biomarker for diagnosis, prognosis, or patient selection
Beyond the preview
Go deeper on NUMA1 antisense RNA 1 (NUMA1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NUMA1 antisense RNA 1 (NUMA1-AS1).